Last $33.29 USD
Change Today -1.90 / -5.40%
Volume 237.4K
As of 5:20 PM 05/22/13 All times are local (Market data is delayed by at least 15 minutes).

Audit Committee* - clovis oncology inc (CLVS)

Name (Connections)Board RelationshipsTitleKey Developments
Edward McKinley 66 RelationshipsDirector and Chairman of Audit Committe 
Paul Klingenstein 48 RelationshipsDirector and Member of Audit Committe 
Brian Atwood MBA 214 RelationshipsDirector, Member of Audit Committee and Member of Nominating & Corporate Governance Committee 

Compensation Committee* - clovis oncology inc (CLVS)

Name (Connections)Board RelationshipsTitle
Michael Barrett Ph.D. 153 RelationshipsChairman, Chairman of Nominating & Corporate Governance Committee and Member of Compensation Committee
James Blair Ph.D. 166 RelationshipsDirector, Chairman of Compensation Committee and Member of Nominating & Corporate Governance Committee
Thorlef Spickschen Ph.D. 10 RelationshipsDirector and Member of Compensation Committee
CLVS Compensation vs. Industry
491.7K
387.9K
Chief Executive Officer
358.8K
276.9K
Chief Financial Officer
Share price activity for CLOVIS ONCOLOGY INC (CLVS)
52 Week Price Performance
CLVS
Industry Average

Nominating Committee* - clovis oncology inc (CLVS)

Name (Connections)Board RelationshipsTitleKey Developments
Michael Barrett Ph.D. 153 RelationshipsChairman, Chairman of Nominating & Corporate Governance Committee and Member of Compensation CommitteeClovis Oncology, Inc. Announces Resignation of Dr. John C. Reed from the Board of Directors
02/19/13
James Blair Ph.D. 166 RelationshipsDirector, Chairman of Compensation Committee and Member of Nominating & Corporate Governance Committee
Brian Atwood MBA 214 RelationshipsDirector, Member of Audit Committee and Member of Nominating & Corporate Governance Committee

Corporate Governance Committee* - clovis oncology inc (CLVS)

Name (Connections)Board RelationshipsTitle
Brian Atwood MBA 214 RelationshipsChairman, Chairman of Nominating & Corporate Governance Committee and Member of Compensation Committee
Michael Barrett Ph.D. 153 RelationshipsDirector, Chairman of Compensation Committee and Member of Nominating & Corporate Governance Committee
James Blair Ph.D. 166 RelationshipsDirector and Member of Compensation Committee
CLVS and Competitor
Insiders vs. External
Board
14%
86%
Clovis Oncology, Inc.
Insiders
External Board Members
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CLVS:US $33.29 USD -1.90

CLVS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for CLVS.
View Industry Companies
 

Industry Analysis

CLVS

Industry Average

Valuation CLVS Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book 7.8x
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CLOVIS ONCOLOGY INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.